BioSalsa

Avanzando Caminos Hispanic/Latino Cancer Survivorship Study

Explore the groundbreaking Avanzando Caminos (Leading Pathways): Hispanic/Latino Cancer Survivorship Study. This six-year observational study, funded by the National Cancer Institute, aims to enroll 3,000 Hispanic/Latino cancer survivors from South Texas and South Florida  We delve into the social, cultural, behavioral, mental, biological, and medical influences on the post-cancer lives of Hispanic/Latino communities    Discover how this study is paving the way for better survivorship experiences and why representation in clinical studies matters.

The Intersection of Public Health and the Medical Laboratory: A Conversation about Research with Dr. Rodney E. Rohde

Dr. Rodney E. Rohde is a Regents’ Professor and Chair of the Medcial Laboratory Science Program at Texas State University, specializing in medical laboratory science, microbiology, and public health. His research focuses on rabies, antibiotic resistance, emerging infectious diseases, and the critical role of medical laboratory professionals in healthcare. A Global Fellow and renowned expert in virology and public health policy, he actively educates and advocates for the laboratory workforce through his writing, speaking engagements, and leadership roles.

Exploring novel treatments for infectious disease, tuberculosis, and cancer

In this episode, Dr. Larry Schlesinger delves into the intricate relationship between infectious diseases and cancer. He highlights he groundbreaking research being conducted at the Texas Biomedical Research Institute, focusing on novel treatments for infectious diseases, tuberculosis, and cancer. Dr. Schlesinger discusses how understanding the links between these conditions can lead to innovative therapeutic approaches.

Unlocking the Future of Lung Cancer Detection

Tune in to learn how this San Antonio Company is making strides in the fight against lung cancer using a non-invasive, early-stage detection test. Join us in this enlightening episode as we dive into the groundbreaking work of bioAffinity Technologies and their CyPath® Lung. Don't miss this inspiring conversation on the future of cancer diagnostics offering hope and improved outcomes for patients worldwide! 🌟